Return to homepagePandemic Pact

Clinical trials and immune responses in the lungs

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-178

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Pending

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Human Immunology Unit at the University of Oxford

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Co-ordinating national and local clinical trial activity. Identifying early immune signals and understanding the mechanisms underlying severe forms of COVID-19 lung disease.